Assessment of tissue factor pathway inhibitor 2 (TFPI2) as a novel serum marker for malignant tumors of the ovary before and after treatment: A case-control study
IF 1.6
4区 医学
Q3 OBSTETRICS & GYNECOLOGY
Pub Date : 2025-02-19
DOI: 10.1111/jog.16241
Yuki Ogawara, Naho Ruiz Yokota, Yuki Yamada, Noriaki Arakawa, Kentaro Sakamaki, Hiroshi Kobayashi, Kazumi Kubota, Fuminori Kimura, Taichi Mizushima, Etsuko Yamazaki, Etsuko Miyagi